113 related articles for article (PubMed ID: 23354116)
1. Chaotropic agents in liquid chromatographic method development for the simultaneous analysis of levodopa, carbidopa, entacapone and their impurities.
Vemić A; Jančić Stojanović B; Stamenković I; Malenović A
J Pharm Biomed Anal; 2013 Apr; 77():9-15. PubMed ID: 23354116
[TBL] [Abstract][Full Text] [Related]
2. Micellar HPLC-UV method for the simultaneous determination of levodopa, carbidopa and entacapone in pharmaceuticals and human plasma.
Belal F; Ibrahim F; Sheribah ZA; Alaa H
J Chromatogr B Analyt Technol Biomed Life Sci; 2018 Aug; 1091():36-45. PubMed ID: 29843067
[TBL] [Abstract][Full Text] [Related]
3. Development and Validation of a RP-HPLC Method for Determination of Related Substances and Degradants in Entacapone.
Purnachand D; Veerareddy A; Ramadevi B; Kameswarrao ChV; Madhusudhanreddy B
J Chromatogr Sci; 2016 Sep; 54(8):1310-23. PubMed ID: 27165569
[TBL] [Abstract][Full Text] [Related]
4. Determination of L-dopa, carbidopa, 3-O-methyldopa and entacapone in human plasma by HPLC-ED.
Bugamelli F; Marcheselli C; Barba E; Raggi MA
J Pharm Biomed Anal; 2011 Feb; 54(3):562-7. PubMed ID: 21035976
[TBL] [Abstract][Full Text] [Related]
5. Development and Validation of a Robust and Efficient HPLC Method for the Simultaneous Quantification of Levodopa, Carbidopa, Benserazide and Entacapone in Complex Matrices.
Wollmer E; Klein S
J Pharm Pharm Sci; 2017; 20(0):258-269. PubMed ID: 28810948
[TBL] [Abstract][Full Text] [Related]
6. Clinical experience with the novel levodopa formulation entacapone + levodopa + carbidopa (Stalevo).
Silver DE
Expert Rev Neurother; 2004 Jul; 4(4):589-99. PubMed ID: 15853578
[TBL] [Abstract][Full Text] [Related]
7. A rapid liquid chromatography/tandem mass spectrometry method for simultaneous determination of levodopa, carbidopa, entacapone and their six related compounds in film-coated tablets.
Burmaoğlu RE; Sağlık Aslan S
Rapid Commun Mass Spectrom; 2020 Jun; 34(12):e8782. PubMed ID: 32170976
[TBL] [Abstract][Full Text] [Related]
8. LC determination of entacapone in tablets: in vitro dissolution studies.
Paim CS; Martins MT; Malesuik MD; Steppe M
J Chromatogr Sci; 2010 Oct; 48(9):755-9. PubMed ID: 20875238
[TBL] [Abstract][Full Text] [Related]
9. Development and validation of a reversed phase liquid chromatographic method for analysis of griseofulvin and impurities.
Kahsay G; Adegoke AO; Van Schepdael A; Adams E
J Pharm Biomed Anal; 2013 Jun; 80():9-17. PubMed ID: 23518305
[TBL] [Abstract][Full Text] [Related]
10. Chemometrically assissted optimization and validation of RP-HPLC method for the analysis of itraconazole and its impurities.
Kasagić I; Malenović A; Jovanović M; Rakić T; Jančić Stojanović B; Ivanović D
Acta Pharm; 2013 Jun; 63(2):159-73. PubMed ID: 23846140
[TBL] [Abstract][Full Text] [Related]
11. Investigation of different spectrophotometric and chemometric methods for determination of entacapone, levodopa and carbidopa in ternary mixture.
Abdel-Ghany MF; Hussein LA; Ayad MF; Youssef MM
Spectrochim Acta A Mol Biomol Spectrosc; 2017 Jan; 171():236-245. PubMed ID: 27541796
[TBL] [Abstract][Full Text] [Related]
12. Chromatographic separation of (E)- and (Z)-isomers of entacapone and their simultaneous quantitation in human plasma by LC-ESI-MS/MS.
Yadav M; Dixit P; Trivedi V; Gandhi A; Senger A; Guttikar S; Singhal P; Shrivastav PS
J Chromatogr B Analyt Technol Biomed Life Sci; 2009 Feb; 877(5-6):533-40. PubMed ID: 19167276
[TBL] [Abstract][Full Text] [Related]
13. Development of characterization methods for entacapone in a pharmaceutical bulk.
Soukhova N; Kassymbek Z; Bradby S; Martin-Esker A; White P; Wahab S
J Pharm Biomed Anal; 2011 Mar; 54(4):860-5. PubMed ID: 21112716
[TBL] [Abstract][Full Text] [Related]
14. Development and application of a high-performance liquid chromatographic method for the determination of in vitro drug release of levodopa, carbidopa, and entacapone from a tablet formulation.
Doshi AS; Upadhyay KJ; Mehta TN; Nanda N
J AOAC Int; 2009; 92(2):394-403. PubMed ID: 19485197
[TBL] [Abstract][Full Text] [Related]
15. Adherence with levodopa/carbidopa/entacapone versus levodopa/carbidopa and entacapone as separate tablets in patients with Parkinson's disease.
Delea TE; Thomas SK; Hagiwara M; Mancione L
Curr Med Res Opin; 2010 Jul; 26(7):1543-52. PubMed ID: 20429819
[TBL] [Abstract][Full Text] [Related]
16. Liquid chromatographic determination of levodopa, levodopa-carbidopa, and related impurities in solid dosage forms.
Ting S
J Assoc Off Anal Chem; 1986; 69(1):169-73. PubMed ID: 3081485
[TBL] [Abstract][Full Text] [Related]
17. Development and validation of a reversed-phase liquid chromatographic method for analysis of demeclocycline and related impurities.
Kahsay G; Maxa J; Van Schepdael A; Hoogmartens J; Adams E
J Sep Sci; 2012 Jun; 35(10-11):1310-8. PubMed ID: 22733511
[TBL] [Abstract][Full Text] [Related]
18. Simultaneous determination of lidocaine hydrochloride, hydrocortisone and nystatin in a pharmaceutical preparation by RP-LC.
Pendela M; Kahsay G; Baekelandt I; Van Schepdael A; Adams E
J Pharm Biomed Anal; 2011 Nov; 56(3):641-4. PubMed ID: 21794999
[TBL] [Abstract][Full Text] [Related]
19. Development and validation of a reversed phase liquid chromatographic method for analysis of oxytetracycline and related impurities.
Kahsay G; Shraim F; Villatte P; Rotger J; Cassus-Coussère C; Van Schepdael A; Hoogmartens J; Adams E
J Pharm Biomed Anal; 2013 Mar; 75():199-206. PubMed ID: 23277151
[TBL] [Abstract][Full Text] [Related]
20. Treatment of end-of-dose wearing-off in parkinson's disease: stalevo (levodopa/carbidopa/entacapone) and levodopa/DDCI given in combination with Comtess/Comtan (entacapone) provide equivalent improvements in symptom control superior to that of traditional levodopa/DDCI treatment.
Brooks DJ; Agid Y; Eggert K; Widner H; Ostergaard K; Holopainen A;
Eur Neurol; 2005; 53(4):197-202. PubMed ID: 15970632
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
